13F-HR filed by EMORY UNIVERSITY
EMORY UNIVERSITY filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-14, with 46 holding rows worth $140,037,000.
- Accession
- 0001377635-18-000004
- Filer
- CIK 1377635
- Filed
- 2018-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, 46 entries on the cover page, a total value of $140,037,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $140,037,000 with VALUE read as thousands by filing date, 13F file number 028-16101. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 084670108 | CL A | 117 | $34,995,000 | thousands by filing date | |
| JD.COM INC SPON ADS CL A | 47215P106 | ADR | 124,490 | $5,041,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 176,387 | $3,752,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 19,170 | $3,221,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 46,933 | $3,069,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 32,163 | $2,949,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 177,342 | $2,807,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 22,474 | $2,777,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 39,066 | $2,658,000 | thousands by filing date | |
| ABLYNX NV | 00372Y105 | SPONSORED ADR | 48,194 | $2,629,000 | thousands by filing date | |
| Inflarx Nv | N44821101 | COM | 90,761 | $2,618,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 16,132 | $2,598,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 172,666 | $2,597,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 115,136 | $2,574,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 30,725 | $2,548,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 63,499 | $2,543,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 21,316 | $2,539,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 30,447 | $2,537,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 179,162 | $2,523,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 48,079 | $2,516,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 30,823 | $2,499,000 | thousands by filing date | |
| GENOMIC HEALTH, INC. | 37244C101 | COM | 79,591 | $2,490,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 62,410 | $2,440,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 21,793 | $2,429,000 | thousands by filing date | |
| CORIUM INTL INC | 21887L107 | COM | 210,559 | $2,415,000 | thousands by filing date | |
| SEAGATE TECHNOLOGY PLC | G7945M107 | SHS | 41,216 | $2,412,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 246,411 | $2,356,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 101,290 | $2,337,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 77,335 | $2,303,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 88,462 | $2,279,000 | thousands by filing date | |
| CBRE GROUP INC CL A | 12504L109 | Stock | 46,888 | $2,214,000 | thousands by filing date | |
| Microsoft Corp | 594918104 | COM | 23,505 | $2,145,000 | thousands by filing date | |
| FOX CORP CLASS B | 90130A200 | COM | 57,218 | $2,081,000 | thousands by filing date | |
| Morgan Stanley | 617446448 | COM | 38,466 | $2,076,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 41,610 | $2,010,000 | thousands by filing date | |
| TRINITY INDS INC | 896522109 | COM | 60,831 | $1,985,000 | thousands by filing date | |
| EXPRESS SCRIPTS HLDG CO | 30219G108 | COM | 28,172 | $1,946,000 | thousands by filing date | |
| KKR & CO LP | 48248M102 | COMMON STOCK | 95,337 | $1,935,000 | thousands by filing date | |
| ARMSTRONG WORLD INDS INC NEW | 04247X102 | COM | 34,238 | $1,928,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 47,886 | $1,920,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 84,714 | $1,904,000 | thousands by filing date | |
| BREAD FINANCIAL HOLDINGS INC | 018581108 | COM | 8,662 | $1,844,000 | thousands by filing date | |
| SUMMIT MIDSTREAM PARTNERS LP | 866142102 | COM UNIT LTD | 87,560 | $1,230,000 | thousands by filing date | |
| COCRYSTAL PHARMA INC | 19188J300 | CMN | 152,916 | $910,000 | thousands by filing date | |
| Amazon.com, Inc | 023135106 | COM | 158 | $229,000 | thousands by filing date | |
| SPY | 78462F103 | SHS | 872 | $229,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001377635-18-000004 | this filing | 2018-05-14 | acceptance time not in the bulk data set |